Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Hematopoietic stem cell transplant: does congenital heart disease matter?

Goyal RK, Feingold B.

Pediatr Transplant. 2011 Feb;15(1):7-8. doi: 10.1111/j.1399-3046.2010.01459.x. No abstract available.

PMID:
21241437
2.

Outcome of hematopoietic stem cell transplant in children with congenital heart disease.

Guinan EC, Hewett EK, Domaney NM, Margossian R.

Pediatr Transplant. 2011 Feb;15(1):75-80. doi: 10.1111/j.1399-3046.2010.01317.x.

PMID:
20345610
3.

Managing the toxicity of hematopoietic stem cell transplant.

Pallera AM, Schwartzberg LS.

J Support Oncol. 2004 May-Jun;2(3):223-37; discussion 237-8, 241, 246-7. Review.

PMID:
15328824
4.

Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue.

Akahori M, Nakamae H, Hino M, Yamane T, Hayashi T, Ohta K, Tatsumi N, Kitagawa S, Tsumura K.

Bone Marrow Transplant. 2003 Apr;31(7):585-90.

PMID:
12692626
5.

Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.

Chandrasekar P, Ljungman PT.

Transplantation. 2008 Jul 27;86(2):183-91. doi: 10.1097/TP.0b013e318177de64. Review.

PMID:
18645475
7.
8.

Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.

Alchalby H, Kröger N.

Curr Hematol Malig Rep. 2010 Apr;5(2):53-61. doi: 10.1007/s11899-010-0044-z. Review.

PMID:
20425397
9.

Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.

Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.

Bone Marrow Transplant. 2007 Jun;39(11):667-75. Epub 2007 Apr 2.

PMID:
17401396
10.

Stem cell transplantation and hematopoietic growth factors.

Richard S, Schuster MW.

Curr Hematol Rep. 2002 Nov;1(2):103-9. Review.

PMID:
12901131
11.

Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.

Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM; GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology..

Biol Blood Marrow Transplant. 2010 Jul;16(7):957-66. doi: 10.1016/j.bbmt.2010.02.003. Epub 2010 Feb 7.

12.

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.

Weissinger EM, Dickinson AM.

Cancer Treat Res. 2009;144:95-129. doi: 10.1007/978-0-387-78580-6_5. Review. No abstract available.

PMID:
19779872
13.
14.

Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.

Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG.

Am J Respir Crit Care Med. 2002 Sep 1;166(5):641-5. Review. No abstract available.

PMID:
12204858
15.

ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.

Worel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A, Höcker P, Kalhs P.

Transfus Apher Sci. 2007 Jun;36(3):297-304. Epub 2007 Jun 13.

PMID:
17569587
16.

Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.

Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF.

Transfusion. 2008 Jan;48(1):163-8. Epub 2007 Sep 27.

PMID:
17900280
17.

Autologous hematopoietic stem cell transplantation for Crohn's disease: high risk for a high reward.

Lashner BA.

Inflamm Bowel Dis. 2005 Aug;11(8):778-9. No abstract available.

PMID:
16043994
18.

Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation.

Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K, Hayashi T, Tsumura K.

Am J Hematol. 2004 May;76(1):1-7.

19.

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation.

Mori T, Aisa Y, Nakazato T, Ikeda Y, Okamoto S.

Int J Hematol. 2005 Jun;81(5):439-40. No abstract available.

PMID:
16158829
20.

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party..

Haematologica. 2008 Aug;93(8):1203-10. doi: 10.3324/haematol.12949. Epub 2008 Jun 12.

Supplemental Content

Support Center